---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-25-000036"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:46:46.544767+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q3 GAAP EPS loss of $3.13 on $5.7B goodwill impairment; raises FY2025 adjusted EPS guide to $6.55-$6.65

## Summary
- Total revenues of $102.9B, up 7.8% YoY; GAAP diluted loss per share of $3.13 includes $5.7B goodwill impairment charge.
- Adjusted EPS of $1.60, above prior year $1.09; FY2025 Adjusted EPS guidance raised to $6.55-$6.65 from $6.30-$6.40.
- Health Care Benefits segment MBR improved to 92.8% from 95.2%; adjusted operating income of $314M vs loss of $924M in prior year.
- Health Services adjusted operating income down 7.0% to $2.05B; Pharmacy & Consumer Wellness down 7.4% to $1.478B.
- Aetna Medicare Advantage Star Ratings: >81% of members in 4-star+ plans; Caremark contract wins of ~$6.0B with high retention.

## SEC filing metadata
- accession: 0000064803-25-000036
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480325000036/0000064803-25-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480325000036/cvs-20251029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-25-000036
- JSON: https://secwatch.observer/filing/0000064803-25-000036.json
- Plain text: https://secwatch.observer/filing/0000064803-25-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.